Cardiovascular

Although mortality rates for cardiovascular diseases declined consistently over the decade 1998-2008, heart disease and stroke are still the number one killer in the US. This fact that illustrates why cardiovascular drugs and therapeutics is such a key sector of the pharmaceutical industry.

The reports, books, and subscriptions listed under Research and Markets’ Cardiovascular category explore in-depth vital areas such as the latest clinical trials for treatments for a variety of afflictions such as hypertension, arrhythmia and stroke. Learn all the latest news about products and R&D of pharmaceutical companies, hospitals and universities, as well as the latest market trends in a wide selection of countries. Also featured is a selection of academic and clinical textbooks for those working at the coalface of cardiovascular pharmaceuticals. Show Less ... more

• Daily Updates: Cardiovascular Diseases - Tracking breaking research, drug development news new trials

  EURO€ 88.00USD$ 82.00GBP£ 50.00AUD$ 120.00JPY¥ 10,092.00SEK 710,00CHF 118.00CAD$ 110.00 Lead Discovery, May 2013
  DailyUpdates was launched in 2002 by the pharmaceutical analysts Lead Discovery to provide the R&D sector with a unique intelligence tool We use proprietary search engine technology to identify breaking...

• Cardiovascular Drug Delivery - Technologies, Markets and Companies

  EURO€ 2,152.00USD$ 2,800.00GBP£ 1,811.00AUD$ 2,739.00JPY¥ 276,452.00SEK 18 384,00CHF 2'639.00CAD$ 2,853.00 Jain PharmaBiotech, May 2013 , Pages: 265
  Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to all organs of...

• Cardiac Fibrosis - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Apr 2013 , Pages: 36
  Cardiac Fibrosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cardiac Fibrosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

• Arrhythmias - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Apr 2013 , Pages: 43
  Arrhythmias – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Arrhythmias - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

• Percutaneous Coronary Intervention - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Apr 2013 , Pages: 51
  Percutaneous Coronary Intervention – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Percutaneous Coronary Intervention - Pipeline Review, H1 2013', provides an overview of the indication’s...

• Cardiomyopathy - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Apr 2013 , Pages: 90
  Cardiomyopathy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cardiomyopathy - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

• Pulmonary Arterial Hypertension - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Apr 2013 , Pages: 147
  Pulmonary Arterial Hypertension – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pulmonary Arterial Hypertension - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

• Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Apr 2013 , Pages: 353
  Congestive Heart Failure (Heart Failure) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2013', provides an overview of...

• Ischemia Reperfusion Injury - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Apr 2013 , Pages: 95
  Ischemia Reperfusion Injury – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ischemia Reperfusion Injury - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

• Vasculitis Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Mar 2013 , Pages: 123
  Vasculitis Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Vasculitis Global Clinical Trials Review, H1, 2013" provides data on the Vasculitis clinical trial scenario....

• Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Mar 2013 , Pages: 68
  Deep Vein Thrombosis (DVT) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

• Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Mar 2013 , Pages: 160
  Peripheral Artery Occlusive Disease (PAOD) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2013', provides an overview...

• Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Mar 2013 , Pages: 315
  Type 1 Diabetes (Juvenile Diabetes) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2013', provides an overview of the indication’s...

• Coronary Disease Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Feb 2013 , Pages: 101
  Coronary Disease Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Coronary Disease Global Clinical Trials Review, H1, 2013" provides data on the Coronary Disease clinical...

• Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Feb 2013 , Pages: 115
  Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013"...

• Edema - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 41
  Edema – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Edema - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

• Pulmonary Hypertension - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 144
  Pulmonary Hypertension – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pulmonary Hypertension - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

• Idiopathic (Essential) Hypertension - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 57
  Idiopathic (Essential) Hypertension – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Idiopathic (Essential) Hypertension - Pipeline Review, H1 2013', provides an overview of the indication’s...

• Angina (Angina Pectoris) - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 81
  Angina (Angina Pectoris) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Angina (Angina Pectoris) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

• Acute Coronary Syndrome - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 115
  Acute Coronary Syndrome – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acute Coronary Syndrome - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

• Myocardial Ischemia - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 59
  Myocardial Ischemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Myocardial Ischemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

• Acute Heart Failure - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 67
  Acute Heart Failure – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acute Heart Failure - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

• Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 131
  Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)...

• Myocardial Infarction - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 235
  Myocardial Infarction – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Myocardial Infarction - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

• Chronic Heart Failure - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 51
  Chronic Heart Failure – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Chronic Heart Failure - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

• Atherosclerosis - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 243
  Atherosclerosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Atherosclerosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

• High Triglyceridemia - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 88
  High Triglyceridemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'High Triglyceridemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

• Atrial Fibrillation - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 88
  Atrial Fibrillation – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Atrial Fibrillation - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

• Ischemia - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 211
  Ischemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ischemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

• Venous Thromboembolism - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 62
  Venous Thromboembolism – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Venous Thromboembolism - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

• Cardiovascular Inflammation - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 75
  Cardiovascular Inflammation – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cardiovascular Inflammation - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

• Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Feb 2013 , Pages: 118
  Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2013',...

• Aortic Aneurysm Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Feb 2013 , Pages: 79
  Aortic Aneurysm Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Aortic Aneurysm Global Clinical Trials Review, H1, 2013" provides data on the Aortic Aneurysm clinical trial...

• Reperfusion Injury Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Feb 2013 , Pages: 77
  Reperfusion Injury Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Reperfusion Injury Global Clinical Trials Review, H1, 2013" provides data on the Reperfusion Injury clinical...

• Hypotension Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Feb 2013 , Pages: 180
  This clinical trial report provides data on the Hypotension clinical trial scenario The report provides elemental information and data relating to the clinical trials on Hypotension It includes an overview...

• Venous Thromboembolism Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Feb 2013 , Pages: 136
  Venous Thromboembolism Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2013" provides data on the Venous Thromboembolism...

• Cardiac Arrest Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Feb 2013 , Pages: 88
  Cardiac Arrest Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Cardiac Arrest Global Clinical Trials Review, H1, 2013" provides data on the Cardiac Arrest clinical trial...

• Hypoxemia Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Feb 2013 , Pages: 72
  Hypoxemia Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Hypoxemia Global Clinical Trials Review, H1, 2013" provides data on the Hypoxemia clinical trial scenario. This...

• Ventricular Tachycardia Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Feb 2013 , Pages: 86
  Ventricular Tachycardia Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Ventricular Tachycardia Global Clinical Trials Review, H1, 2013" provides data on the Ventricular...

• Thromboembolism Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Feb 2013 , Pages: 139
  Thromboembolism Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Thromboembolism Global Clinical Trials Review, H1, 2013" provides data on the Thromboembolism clinical trial...

• Orthostatic Hypotension Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Feb 2013 , Pages: 151
  This clinical trial report, Orthostatic Hypotension Global Clinical Trials Review, H1, 2013 provides data on the Orthostatic Hypotension clinical trial scenario This report provides elemental information...

• Regurgitation Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Feb 2013 , Pages: 89
  This clinical trial report, Regurgitation Global Clinical Trials Review, H1, 2013 provides data on the Regurgitation clinical trial scenario The report provides elemental information and data relating...

• Ventricular Fibrillation Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Jan 2013 , Pages: 63
  This clinical trial report, Ventricular Fibrillation Global Clinical Trials Review, H1, 2013, provides data on the Ventricular Fibrillation clinical trial scenario The report provides elemental information...

• Chronic Stable Angina Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Jan 2013 , Pages: 83
  Chronic Stable Angina Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Chronic Stable Angina Global Clinical Trials Review, H1, 2013" provides data on the Chronic Stable...

• Bradycardia Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Jan 2013 , Pages: 69
  Bradycardia Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Bradycardia Global Clinical Trials Review, H1, 2013" provides data on the Bradycardia clinical trial scenario....

• Mitral Regurgitation Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Jan 2013 , Pages: 75
  Mitral Regurgitation Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Mitral Regurgitation Global Clinical Trials Review, H1, 2013" provides data on the Mitral Regurgitation...

• Atrial Flutter Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Jan 2013 , Pages: 210
  Atrial Flutter Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Atrial Flutter Global Clinical Trials Review, H1, 2013" provides data on the Atrial Flutter clinical trial...

• Pulmonary Edema Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Jan 2013 , Pages: 70
  Pulmonary Edema Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Pulmonary Edema Global Clinical Trials Review, H1, 2013" provides data on the Pulmonary Edema clinical trial...

• Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Jan 2013 , Pages: 73
  Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013" provides data on the Abdominal...

• Portal Hypertension Global Clinical Trials Review, H1, 2013

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Jan 2013 , Pages: 83
  Portal Hypertension Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Portal Hypertension Global Clinical Trials Review, H1, 2013" provides data on the Portal Hypertension...